A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
ImmunityBio, Inc.
University of Pittsburgh
Rain Oncology Inc
Fate Therapeutics
MultiVir, Inc.